Detalhe da pesquisa
1.
Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis.
J Intern Med
; 293(5): 636-647, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37018129